An interventional study of Case formulation with web-program in Persistent Physical Symptoms, Indoor Environment Associated Symptoms and Indoor Air Associated Symptoms, sponsored by Finnish Institute of Occupational Health. Status unknown at 1 site in Finland. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2023-01-04.
Sponsored by Finnish Institute of Occupational Health · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Persistent physical symptoms (PPS) might diminish studying or workability and daily functioning without a clear medical or environment-related explanation. Psychosocial, patient-involving treatments that support individuals' abilities managing with the PPS and health behaviours have shown promising effects in treating PPS but the acceptability of these treatments among symptomatic individuals is low.
This study aims to assess the effectiveness of an eHealth intervention based on relational frame theory and acceptance and commitment therapy on PPS with two focus groups, among participants with indoor air associated disabling symptoms or persistent, chronic fatigue.
This study will compare web program enhanced with video-based individual case formulation with treatment as usual. The web program includes 10 one weeks (pilot included 6 two weeks) modules. In addition to patient-reported outcomes, ecological momentary assessments are conducted to provide real-time data on functioning and national registers are used to obtain information on health-care use and social benefits.
Data collection begins in August 2020 and will continue until 2023.
Background: Frequent physical symptoms are common in the general population with over 90 per cent of the population reporting symptoms at some level. In some cases, they become persistent diminishing workability and daily functioning and associate with increased healthcare usage and sick leaves independently of other somatic or psychiatric comorbidities. Persistent physical symptoms (PPS) challenge health care systems as it is estimated that up to 4-30 per cent of primary health care visits are due to PPS without a clear medical explanation. Psychosocial, patient-involving treatments, such as cognitive-behavioural psychotherapy (CBT), that support individuals' abilities managing with the PPS and health behaviours have shown promising effects in treating PPS but so far, evidence-based treatments have resulted only in small to moderate effect sizes. The acceptability of these treatments among symptomatic individuals is also low - presumably because of the stigma related to the ambiguity of the PPS´ status as a medical condition. A stronger orientation to personalized treatment protocols is needed to improve the treatment efficacy and applicability.
This study will assess the effects of an eHealth intervention based on relational frame theory and acceptance and commitment therapy on PPS with two focus groups, among participants with indoor air associated disabling symptoms or persistent, chronic fatigue.
Methods: Using a randomized controlled design (RCT) with two parallel groups in a 1:1 ratio, the investigators will compare ACT/RFT-based web program enhanced with individual case formulation with treatment as usual. The web program intervention includes 10 one weeks (pilot included 6 two weeks) modules that each ask to complete the module and included training in two weeks. The web program is in Finnish. Participants will be asked to complete outcome questionnaires at baseline before the interview for inclusion, after the interview (randomization) and at 3, 6- and 12-months' follow-up after the randomization. The intervention group receives also a questionnaire four weeks after the beginning of the web program. In addition, ecological momentary assessments are also conducted to provide real-time data on functioning and national registers are used to obtain information on healthcare use and social benefits to complete patient-reported outcomes.
Eligible participants will be randomized to either the intervention or to TAU. The primary outcome will be a health-related quality of life. The secondary outcome measures are symptoms, illness perceptions, psychological flexibility and workability. Further, the investigators will assess whether any effect of the intervention on the primary outcome is mediated by the case formulation. The baseline data collection begins in August 2020 and will continue until 2022, follow-up data collection will continue until 2023.
265 studies on the registry are indexed under Fatigue Syndrome, Chronic; 63 are open to participants now.
This study's enrollment of 105 is above the median of 60 across 179 interventional studies indexed under Fatigue Syndrome, Chronic.
Browse Fatigue Syndrome, Chronic studies →Finnish Institute of Occupational Health is the lead sponsor of 13 studies on the registry; 2 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
A) Indoor air-related symptoms
or
B) Chronic fatigue
Multiorgan symptoms i) Pain, often widespread, ii) Two of more neurological or cognitive symptoms, iii) At least two symptoms of following categories: Autonomic manifestations, neuroendocrine manifestations or immune manifestations
Exclusion Criteria:
Medical reasons
The intervention will start with two video meetings with a psychologist to build up and present an individual case formulation, based on behavioural analysis, and to build up a shared decision of individual goals for the web program. The intervention continues with a web program consisting of ten manualized web-based modules, each at one-week intervals based on relational frame theory (RFT) and acceptance and commitment therapy (ACT). The pilot programme included six two-weeks modules and it was in use until 5/2021. The programme is in Finnish. Both participants in the intervention arm and in the treatment as the usual arm will receive usual care, meaning that TAU will be enhanced with the study intervention in the intervention arm. In addition to TAU, all participants will be given self-help and educational leaflet based on scientific knowledge related to their condition.
Behavioral: Case formulation with web-program
Treatment as usual includes all the routine care that individual receives when he or she is presenting his or her symptoms at the primary or the occupational health care unit (corresponds primary care level treatment) or other unit that recommends the study for the participant. In practice, TAU may vary between the study participants based on their individual needs e.g. treatments for co-morbid somatic diseases or psychiatric disorders that this study will not interfere. Both participants in the intervention arm and in the treatment as usual arm will receive usual care, meaning that TAU will be enhanced with the study intervention in the intervention arm. In addition to TAU all participants will be given self-help and educational leaflet based on scientific knowledge related to their condition.
The first meeting includes an interview to establish understanding on the participant´s symptomatology and current life situation, a case formulation (CF) will be build based on it. The CF is presented in the second session and modifications can be made to ensure acceptability for the participant. Goals for web program (WB) are set based on the CF and understanding of the factors contributing to the participant´s wellbeing. WB modules are instructed to complete during the week. Modules include psychoeducation, experiential exercises and training aimed at improving wellbeing and psychological flexibility. Web-therapist will offer written feedback. The participants can contact the therapist via the WB and al messages will be replied within one week. Automatic reminders will be sent if a participant has not been active in the WB, the therapists will call participants who have discontinued using the WB.
The 15D questionnaire (health related quality of life)
The 15D is a utility-based generic, standardized measure, comprising the following 15 dimensions that describe physical, mental, and social well-being: mobility, vision, hearing, breathing, sleeping, eating, speech, excretion, usual activities, mental function, discomfort and symptoms, depression, distress, vitality, and sexual activity. Each dimension is graded by the respondent on a scale ranging between 1 and 5, where 1 indicates an experience of no problems at all with the dimension and 5 indicates severe problems. Thus, the 15D can be used to measure a vast number of health states. We will use the 15D data both to derive 15D overall scores with values from 1 (full health) to 0 (being dead), and to obtain dimensional symptom profiles.
Time frame: Chance from baseline (i.e. at self-referral) to after randomisation (i.e. after clinical assessment), and to 6 and 14 weeks and to 6 and to 12 months after randomisation
Demographic questions: age (years)
Time frame: At baseline (i.e. at self-referral)
Demographic questions: gender (male, female, prefer not to say)
Time frame: At baseline (i.e. at self-referral)
Demographic questions: marital status (Unmarried, married or cohabiting, divorced or separation, widow)
Time frame: At baseline (i.e. at self-referral)
Demographic questions: education (basic, secondary, higher)
Time frame: At baseline (i.e. at self-referral)
Demographic questions: daily exercise
One item of the frequency of the exercise on a six point likert scale (No weekly exercise - 4 times/week or more)
Time frame: At baseline (i.e. at self-referral)
Demographic questions: Diet
Two items of the diet on a six point likert scale (have daily regular eating habits - have no regular eating habits; Caffeine consumption never - 7 or more proportion per day)
Time frame: At baseline (i.e. at self-referral)
Social support and loneliness
Five questions of frequency of perceived loneliness and and social support in challenging situations (likert scale).
Time frame: At baseline (i.e. at self-referral), and 12 months after randomisation
Smoking, Alcohol Use Disorders Identification Test (Audit-C)
Time frame: At baseline (i.e. at self-referral), and 12 months after randomisation
Questions about health: Self-reported health
Five point likert scale (very poor - very good)
Time frame: At baseline (i.e. at self-referral), and 12 months after randomisation
Questions about health: Self-reported diseases (diagnosed by medical doctor)
Time frame: At baseline (i.e. at self-referral), and 12 months after randomisation
Questions about health: medication
Self-reported medication during past four weeks (name, dose, purpose of use)
Time frame: At baseline (i.e. at self-referral), and 12 months after randomisation
Questions about health: Health care unit
An open question of the participant´s health care provider.
Time frame: At baseline (i.e. at self-referral), and 12 months after randomisation
Questions about health: Information seeking
Questions about health information seeking from different sources (on a six point likert scale)
Time frame: At baseline (i.e. at self-referral), and 12 months after randomisation
Questions about health: height in meters
height in meters to calculate BMI kg/m\^2
Time frame: At baseline (i.e. at self-referral)
Questions about health: weight in kilograms
weight in kilograms to calculate BMI kg/m\^2
Time frame: At baseline (i.e. at self-referral)
Work characteristics
Questions about participant work characteristics (working hours, field of industry etc)
Time frame: At baseline (i.e. at self-referral), and 12 months after randomisation
Symptoms related to environmental factors
Questions whether environmental factors such as mold or water damage in buildings, electromagnetic fields, chemicals or indoor air have associated with symptoms and have they associated with avoidance behavior (yes - no).
Time frame: At baseline (i.e. at self-referral), and 6 and 14 weeks and 6 and 12 months after randomisation
Health worries and health worries related to environmental factors
Questions about health worries in general and related to environmental factors (scale 0 not worried at all - 10 extremely worried)
Time frame: At baseline (i.e. at self-referral), and 14 weeks, and 6 and 12 months after randomisation
Environmental factors: influence on everyday life
Questions about the influence of environmental factors on everyday life (scale 0 no consequences - 10 severe consequences)
Time frame: At baseline (i.e. at self-referral), and 14 weeks, and 6 and 12 months after randomisation
Resiliency (SOC-3)
Time frame: Time Frame: At baseline (i.e. at self-referral)
Personality Inventory (PK5)
Time frame: Time Frame: At baseline (i.e. at self-referral)
Questions about sleep quality, sleeping patterns
Length of sleep (weekdays and weekends, hours)
Time frame: At baseline (i.e. at self-referral), and 14 weeks, and, 6 and 12 months after randomisation
Questions about sleep quality, sleeping patterns
Nap (frequency per week and length, hours)
Time frame: At baseline (i.e. at self-referral), and 14 weeks, and 6 and 12 months after randomisation
Questions about sleep quality, sleeping patterns
Self-reported i) sleep quality, ii) night awakening iii) sleep disorders and iv) frequency of sleeping medicine usage at five point likert scale.
Time frame: At baseline (i.e. at self-referral), and 14 weeks, and 6 and 12 months after randomisation
Questions about sleep quality, sleeping patterns
Self-reported quality of rest and rhythmicity at four point likert scale.
Time frame: At baseline (i.e. at self-referral), and 14 weeks, and 6 and 12 months after randomisation
Fatigue
Questionnaire about perceived fatigue and its´consequences on daily functioning during past six months.
Time frame: At baseline (i.e. at self-referral), and 14 weeks, and 6 and 12 months after randomisation
Generalized Anxiety Disorder 7 (GAD-7)
Time frame: At baseline (i.e. at self-referral), and 14 weeks, and 6 and 12 months after randomisation
Insomnia Severity Index (ISI)
Time frame: At baseline (i.e. at self-referral), and 14 weeks, and 6 and 12 months after randomisation
Patient Health Questionnaire-15 (PHQ-15)
Time frame: At baseline (i.e. at self-referral), and 14 weeks, and 6 and 12 months after randomisation
The Patient Health Questionnaire (PHQ-9)
Time frame: At baseline (i.e. at self-referral), and 14 weeks, and 6 and 12 months after randomisation
AIDO Healthcare app: daily mood and fatigue
Time frame: 1.5, 3.5 and 12 months after randomisation
The Acceptance and Action Questionnaire -II AAQ-7
Time frame: At baseline (i.e. at self-referral), and 6 and 14 weeks and, 6 and 12 months after randomisation
Comprehensive assessment of Acceptance and Commitment Therapy CompACT
Time frame: At baseline (i.e. at self-referral), and 14 weeks, 6 and 12 months after randomisation
Cognitive Fusion Questionnaire (CFQ-7)
Time frame: At baseline (i.e. at self-referral), and 6 and 14 weeks and, 6 and 12 months after randomisation
Whiteley index -7 questionnaire
Time frame: At baseline (i.e. at self-referral), and 14 weeks and 6 and 12 months after randomisation
White Bear Suppression Inventory (WBSI)
Time frame: At baseline (i.e. at self-referral), after randomization and 14 weeks and, 6 and 12 months after randomisation
Five Facet Mindfulness Questionnaire (FFMQ)
Time frame: At baseline (i.e. at self-referral), after randomization and 12 months after randomisation
Toronto alexithymia scale (TAS-20)
Time frame: At baseline (i.e. at self-referral)
Illness Perception Questionnaire
Time frame: At baseline (i.e. at self-referral) and 6 and 14 weeks and 6 and 12 months after randomisation
Self-assessed current ability to study or work
One question about current ability to study or work on a scale 1-10.
Time frame: At baseline (i.e. at self-referral) and 14 weeks 6 and 12 months after randomisation
Own prognosis of ability to study or work two years from now
One question about of work ability two years from now (scale Unlikely; Not certain; Relatively certain)
Time frame: At baseline (i.e. at self-referral) and 14 weeks 6 and 12 months after randomisation
Self-assessed stress and recovery
One question about stress and recovery on a scale 1-10.
Time frame: At baseline (i.e. at self-referral) and 14 weeks and 6 and 12 months after randomisation
Daily functioning in three sub-domains.
Three questions about daily functioning (work, social life, home) on a scale 1-10 each
Time frame: At baseline (i.e. at self-referral and 14 weeks and 6 and 12 months after randomisation
Working Alliance Inventory (WAI) - patient version for eHealth intervention
Time frame: after randomization and 6 and 14 weeks after randomisation
Treatment satisfaction
Six items of treatment satisfaction based on Seligman´s report (1995). The effectiveness of psychotherapy: The Consumer Reports study. American psychologist, 50(12), 965.
Time frame: after randomization and 6 and 14 weeks after randomisation
Interview of treatment acceptance
Interview for sample of intervention participants about the treatment acceptance (qualitative)
Time frame: 12 months randomisation
Engagement to the intervention
Total number of logins and time during the web-program, modules and exercises completed.
Time frame: 14 weeks after randomisation.
Reasons for discontinuing
If participant discontinues he / she will be contacted.
Time frame: Through study completion, an average of 1 year
The Finnish national health registers
The Finnish national health registers to assess health care expenditures: Data on outpatient visits (AvoHILMO data), data on inpatient care (HILMO data), data on occupational health care use, information on prescribed and reimbursed prescription medicines purchases, information on rights for special reimbursement for medicines and information on sickness and disability benefits and rehabilitation with diagnoses
Time frame: At baseline (i.e. at self-referral), at 12 months after randomisation
Plan to share: No — All IPD that underlie results in a publication could be published But: study participants choose in informed consent that do they accept that their IPD will be published (anonymized). If they choose 'no´, their data won´t be published. Thus the preliminary plan is not to share the IPD (´undecided' would be accurate as well).
No publications or documents are linked to this record.
Started Aug 2020 (actual). Primary completion is estimated for Jul 2023, 34 months after the start.
Of 73 non-industry interventional studies with no phase under Fatigue Syndrome, Chronic, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 43. This study's planned 34 months is above that.
Counting every sponsor, half of 78 studies reached it within 23 months; a quarter within 11 and three quarters within 43.
How these figures are worked out, and which studies are left out of them.
This study is status unknown, as verified in Jan 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Finnish Institute of Occupational Health